The Latest Cardiac and Vascular News
Authors: Denis Roy1, Suzanne Romano2, Jay W. Mason3, Monica Wynn2, Charles Pollack4, Gary Elliot5, Mireille Gillings2, Jerome B. Riebman2 SAN DIEGO, April 24, 2025 /PRNewswire/ — HUYABIO International today announced the presentation of new patient data for HBI-3000, a novel bioinspired…
Birmingham, Alabama – April 24, 2025 – Rampart IC, a medical technology company developing market leading radiation safety and orthopedic protection solutions for the interventional suite, today announced the successful completion of its $21.6M Series B financing round. The round was led by Vensana Capital, a leading venture capital firm […]
ew investment fuels growth of ECG-AI platform and development of perioperative AI capabilities CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, a leading AI-driven health technology company, has expanded beyond its diagnostic ECG-AI™ technology into perioperative and acute cardiac care. The company recently brought on Boston Scientific Corporation as a new investor in its Series […]
Vbeam Pro will be unveiled at the 2025 Annual Meeting of American Society for Laser Medicine and Surgery (ASLMS) MARLBOROUGH, Mass., April 24, 2025 /PRNewswire/ — Candela Corporation, a global leader in energy-based medical aesthetics, proudly announced the launch of the Vbeam Pro…
Published in the International Journal of Cardiology, new study demonstrates 91.6% accuracy and introduces the HF-index for on-demand severity tracking TOKYO, April 24, 2025 /PRNewswire/ — Simplex Quantum, in collaboration with the University of Tokyo Hospital, today announced the…
DENVER, April 24, 2025 /PRNewswire/ — CardioOne, a national growth and operational partner supporting independent cardiology practices, today announced the acquisition of CardioDiagnostics, an advanced cardiac monitoring platform. This acquisition marks a major strategic milestone,…
THE WOODLANDS, TX, April 24, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced its technology and early proof-of-concept study results will be featured in a poster presentation as part of PCR Innovators Day at the world-leading course in interventional cardiovascular medicine, EuroPCR, being held May 20-23, 2025 in Paris, France.
Comprehensive analysis of real-world data shows significant clinical and medico-economic advantages of Implicity’s universal, alert-based remote monitoring platform CAMBRIDGE, Mass., April 24, 2025 /PRNewswire/ — IMPLICITY®, a leader in remote patient monitoring and cardiac data…
– Topline results expected in Q3 2025 – SOUTHLAKE, Texas, April 24, 2025 /PRNewswire/ — Renibus Therapeutics® (“Renibus”), a clinical late-stage biopharmaceutical company focusing on the prevention and treatment of cardiac, renal, and metabolic diseases, today announced the completion of…
– Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month – KYOTO, Japan, April 24, 2025 /PRNewswire/ — OMRON Healthcare Co., Ltd. (Head Office: Muko, Kyoto Prefecture; hereinafter…
